Paul E. Freiman - May 28, 2024 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Director
Signature
/s/ Justin Hall as attorney in fact for Paul E. Freiman
Stock symbol
NBY
Transactions as of
May 28, 2024
Transactions value $
$0
Form type
4
Date filed
5/30/2024, 09:29 PM
Previous filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBY Restricted Stock Units Award $0 +30K $0.00 30K May 28, 2024 Common Stock 30K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on the one year anniversary of the date of grant. The number of restricted stock units and related contingent right to receive common stock does not give effect to the 1-for-35 reverse stock split the issuer effected on May 30, 2024.